Equities

BioArctic AB

BioArctic AB

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)189.60
  • Today's Change4.20 / 2.27%
  • Shares traded276.46k
  • 1 Year change-19.66%
  • Beta0.0768
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,112805848
Total Receivables, Net7.117.969.04
Total Inventory------
Prepaid expenses347.504.34
Other current assets, total0.000.00--
Total current assets1,153821862
Property, plant & equipment, net313534
Goodwill, net------
Intangibles, net------
Long term investments1.651.611.59
Note receivable - long term------
Other long term assets0.00----
Total assets1,186858898
LIABILITIES
Accounts payable302112
Accrued expenses4331--
Notes payable/short-term debt000
Current portion long-term debt/capital leases2.838.868.09
Other current liabilities, total499.7781
Total current liabilities12571101
Total long term debt2.151.187.79
Total debt4.981016
Deferred income tax12--0
Minority interest------
Other liabilities, total--0.000.00
Total liabilities14072109
SHAREHOLDERS EQUITY
Common stock1.771.761.76
Additional paid-in capital------
Retained earnings (accumulated deficit)1,044784786
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.960.960.96
Total equity1,047786789
Total liabilities & shareholders' equity1,186858898
Total common shares outstanding888888
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.